332 filings
Page 5 of 17
DEFA14A
3x66uoo2mxhhi2 o1eyu
30 Sep 22
Additional proxy soliciting materials
4:30pm
8-K
cye63mqaxc4q1nm
30 Sep 22
Entry into a Material Definitive Agreement
4:06pm
8-K
w2yi8kis01t3h3 005
30 Sep 22
Entry into a Material Definitive Agreement
4:00pm
8-K
dh6ce4ug3
30 Aug 22
Other Events
9:00am
DEFA14A
qusgk9r6a
26 Aug 22
Additional proxy soliciting materials
4:03pm
8-K
huriyasbze4lz73neoop
17 Aug 22
T2 Biosystems Announces Second Quarter 2022 Financial Results
4:00pm
NT 10-Q
5eq1i 31zs
16 Aug 22
Notice of late quarterly filing
6:07am
8-K
i9quomvf yyyz73r
9 Aug 22
T2 Biosystems to Explore Potential to Develop Rapid Molecular Diagnostic Test for Philip Trip Taylor, Gilmartin Group
8:31am
8-K
lc8 9s75y
25 Jul 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
10:00am
8-K
5k57a
11 Jul 22
T2 Biosystems Receives FDA Breakthrough Device Designation for the T2Lyme Panel
8:30am
8-K
s6bjddr1gzn3po0y9v4
6 Jul 22
T2 Biosystems Announces Preliminary Second Quarter 2022 Financial Results
8:43am
8-K
hs159s6uyo1
10 Jun 22
Other Events
8:50am
8-K
rzrunlw vb06w4
24 May 22
Other Events
5:01pm
8-K
09yv0mev467bnwut3z
11 May 22
T2 Biosystems Announces First Quarter 2022 Financial Results
4:25pm
8-K
rjkghpy881m c6288
27 Apr 22
T2 Biosystems Announces Submission for FDA Breakthrough Device Designation for T2Biothreat Panel
8:30am
8-K
g7kgyon ebudtlfig
12 Apr 22
Regulation FD Disclosure
4:01pm